Evidence map›Paper›PMID 20851130›Full record

ArticleJournal of molecular biology2010

Internalizing cancer antibodies from phage libraries selected on tumor cells and yeast-displayed tumor antigens.

Yu Zhou, Hao Zou, Shaoyi Zhang, James D Marks

Abstract read
In one paragraph

Article in Journal of molecular biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Discovery of internalizing antibodies to basal breast cancer cells.Protein engineering, design & selection : PEDS · 2018
    Article
  4. Review
  5. Review
  6. Article
  7. Ligand-targeted theranostic nanomedicines against cancer.Journal of controlled release : official journal of the Controlled Release Society · 2016
    Review
  8. Article
  9. Targeted endothelial nanomedicine for common acute pathological conditions.Journal of controlled release : official journal of the Controlled Release Society · 2015
    Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Yu ZhouDepartment of Anesthesia and Pharmaceutical Chemistry, University of California, San Francisco, Room 3C-38,San Francisco General Hospital, 1001 Potrero Avenue, San Francisco, CA 94110, USA.
Hao Zou
Shaoyi Zhang
James D Marks
San Francisco General Hospital · USUniversity of California, San Francisco · US

Funding

Tissue and Outcomes CoreP50CA058207 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRAY, JOE W. · 1992 to 2012
$32.7M
NCI NIH HHS P50 CA058207NCI NIH HHS P50-CA58207
6 · The paper itself

Abstract

A number of approaches have been utilized to generate antibodies to cancer cell surface receptors that can be used as potential therapeutics. A number of these therapeutic approaches, including antibody-drug conjugates, immunotoxins, and targeted nucleic acid delivery, require antibodies that not only bind receptor but also undergo internalization into the cell upon binding. We previously reported on the ability to generate cancer cell binding and internalizing antibodies directly from human phage antibody libraries selected for internalization into cancer cell lines. While a number of useful antibodies have been generated using this approach, limitations include the inability to direct the selections to specific antigens and to identify the antigen bound by the antibodies. Here we show that these limitations can be overcome by using yeast-displayed antigens known to be associated with a cell type to select the phage antibody output after several rounds of selection on a mammalian cell line. We used this approach to generate several human phage antibodies to yeast-displayed EphA2 and CD44. The antibodies bound both yeast-displayed and mammalian cell surface antigens, and were endocytosed upon binding to mammalian cells. This approach is generalizable to many mammalian cell surface proteins, results in the generation of functional internalizing antibodies, and does not require antigen expression and purification for antibody generation.

Indexed as

EndocytosisAntibodies, NeoplasmAntigens, NeoplasmCell Line, TumorDrug Evaluation, PreclinicalHumansHyaluronan ReceptorsProtein BindingProtein TransportReceptor, EphA2Recombinant ProteinsSaccharomyces cerevisiaeAntibodies, NeoplasmAntigens, NeoplasmCD44 protein, humanHyaluronan ReceptorsReceptor, EphA2Recombinant Proteins

Identifiers

PMID20851130
PMCPMC4195448
OpenAlexW1997703904

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.